ILMN

Illumina Inc

265.50

Oct 21 • 7:32 AM ET -2.43 (-0.91%)

Healthcare Diagnostics & Research USA Large NASD

Peers: TMO A DHR PACB QGEN RVTY NTRA TXG GH BRKR

| Held by: VTI VOO VB IVV VBK SPY IBB XLV RSP IWR

Index	S&P 500
Market Cap	40.09B
Enterprise Value	41.45B
Income	825.00M
Sales	4.50B
Book/sh	18.79
Cash/sh	7.74
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	0.00%
Employees	8600
IPO	Jul 28, 2000

P/E	49.48
Forward P/E	43.55
PEG	3.36
P/S	8.92
P/B	14.13
P/C	34.32
P/FCF	43.06
EV/EBITDA	35.55
EV/Sales	9.22
Quick Ratio	1.40
Current Ratio	1.80
Debt/Eq	0.89
LT Debt/Eq	0.69
Option/Short	Yes / Yes

EPS (ttm)	5.37
EPS next Y	6.10
EPS next Q	1.36
EPS this Y	10.65%
EPS next Y	13.84%
EPS next 5Y	12.98%
EPS past 3/5Y	- 4.22%
Sales past 3/5Y	-1.82% 6.02%
EPS Y/Y TTM	-31.78%
Sales Y/Y TTM	4.97%
EPS Q/Q	-9.61%
Sales Q/Q	9.84%
Earnings	Oct 29 AMC
EPS/Sales Surpr.	6.83% 2.51%

Insider Own	0.34%
Insider Trans	-85.66%
Inst Own	114.49%
Inst Trans	4.51%
ROA	12.95%
ROE	32.38%
ROIC	17.25%
Gross Margin	66.81%
Oper. Margin	19.87%
Profit Margin	18.35%
SMA20	-2.10%
SMA50	11.37%
SMA200	54.72%
Trades

Shs Outstand	151.00M
Shs Float	150.48M
Short Float	6.29%
Short Ratio	3.45
Short Interest	9.47M
52W High	309.35 -14.17%
52W Low	94.00 182.45%
Volatility	4.80% 5.42%
ATR (14)	12.87
RSI (14)	54.43
Beta	1.45
Rel Volume	0.01
Avg Volume	2.75M
Volume	1,504

Perf Week	-2.30%
Perf Month	7.29%
Perf Quarter	34.87%
Perf Half Y	103.45%
Perf YTD	102.42%
Perf Year	168.29%
Perf 3Y	128.35%
Perf 5Y	-33.62%
Perf 10Y	92.66%
Recom	2.42
Target Price	250.05
Prev Close	267.93
Price	265.50
Change %	-0.91%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-09-26	Resumed	UBS	Buy	$260
Jun-26-26	Resumed	Bernstein	Mkt Perform	$185
Jun-10-26	Upgrade	JP Morgan	Neutral → Overweight	$185
May-15-26	Resumed	RBC Capital Mkts	Outperform	$170
May-14-26	Upgrade	Daiwa Securities	Neutral → Outperform	$155
Aug-12-25	Downgrade	Daiwa Securities	Outperform → Neutral	$94
Jul-11-25	Downgrade	Scotiabank	Sector Outperform → Sector Perform	$125
Mar-04-25	Reiterated	Citigroup	Neutral	$130 → $90
Feb-28-25	Downgrade	HSBC Securities	Buy → Hold	$100
Feb-10-25	Downgrade	Barclays	Equal Weight → Underweight	$130 → $100
Feb-07-25	Downgrade	TD Cowen	Buy → Hold	$177 → $140
Dec-11-24	Downgrade	Citigroup	Buy → Neutral	$190 → $165
Nov-12-24	Resumed	Morgan Stanley	Equal-Weight	$156
Oct-17-24	Upgrade	HSBC Securities	Hold → Buy	$180
Aug-28-24	Upgrade	Argus	Hold → Buy
Aug-16-24	Upgrade	Daiwa Securities	Neutral → Buy	$120 → $154
Aug-14-24	Upgrade	TD Cowen	Hold → Buy	$126 → $144
Aug-14-24	Upgrade	Barclays	Underweight → Equal Weight	$125
Jul-10-24	Upgrade	Citigroup	Neutral → Buy	$140
Jun-03-24	Resumed	Jefferies	Hold	$115

Show Previous Ratings

Oct-20-26 04:05PM	Illumina To Webcast Upcoming Investor Conference (PR Newswire)
Oct-14-26 08:08PM	Iambic, an AI drug discovery specialist, banks $150M in an IPO (BioPharma Dive)
09:15AM	Illumina launches BioInsight Platform, its first unified software environment to help accelerate genomic and multiomic breakthroughs (PR Newswire)
Oct-09-26 04:30PM	Illumina Inc. stock outperforms competitors on strong trading day (MarketWatch) +5.14%
10:19AM	Could You Have Seen The Run In Tempus AI Stock Coming? (Trefis)
04:06PM	Loading…
Oct-08-26 04:06PM	Illumina to Announce Third Quarter 2026 Financial Results on Thursday, October 29, 2026 (PR Newswire)
09:15AM	Illumina releases SpliceAI2 to help advance rare disease research (PR Newswire)
Oct-05-26 04:30PM	Illumina Inc. stock outperforms competitors on strong trading day (MarketWatch) +7.56% -6.86%
Sep-25-26 06:29PM	What Needs To Be True To Buy Twist Bioscience Stock Now? (Trefis)
10:07AM	Illumina Stock Popped 7% to a 52-Week High. Heres Where the Stock Goes From Here (TIKR)
Sep-23-26 08:39AM	FDA advisers are reviewing a multicancer-detection test. Medicare coverage could follow. (MarketWatch)
Sep-20-26 09:25AM	Illumina Stock Is Up 133% This Year. Heres Where It Could Go Further. (TIKR)
Sep-14-26 01:17PM	Intel Upgraded, CVS Health Downgraded: Updated Rankings on Top Blue-Chip Stocks (InvestorPlace)
Sep-09-26 04:34PM	S&P Dow Jones Indices CEO on Index Restructuring (Bloomberg)
Sep-08-26 08:38PM	3 Stocks Soon Joining the S&P 500 (Zacks)
03:37PM	Loading…
03:37PM	ILMN Stock Keeps Climbing. Should You Climb On? (Trefis)
11:48AM	Bloom Energy Stock Rallies on News of S&P 500 Addition (Investopedia)
11:33AM	Bloom Energys S&P 500 Entry Could Bring A New Wave Of Buyers, Says Clear Street Projects 20% Upside In BE Stock (Stocktwits)
08:16AM	Bloom Energy Joins the S&P 500 as The Trade Desk Leaves (GuruFocus.com)
05:59AM	Premarket movers: Energy stocks rise on Iran tensions, Eaton jumps on UBS upgrade (Investing.com)
Sep-07-26 05:45PM	S&P 500 Adds 3 Surging Stocks in Major Shake-Up (GuruFocus.com)
Sep-04-26 07:42PM	BE, P, ILMN Join S&P 500; LNG Misses Out Bloom Energy Stock Gains While Cheniere Energy Slips (Stocktwits)
07:15PM	Bloom Energy, Illumina, and Everpure Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400, and S&P SmallCap 600 (PR Newswire)
06:16PM	Bloom Energy and These 2 Stocks Are Joining the S&P 500 (Barrons.com)
06:09PM	Bloom Energy, Illumina, and Everpure set to join S&P 500 in quarterly rebalance (Investing.com)
Aug-27-26 03:41PM	Top Research Reports for Goldman Sachs, TotalEnergies & Prologis (Zacks)
Aug-24-26 02:23PM	What Is Really Moving Tempus AI Stock Right Now? (Trefis)
Aug-05-26 09:40AM	Best Buy downgraded, Bristol Myers upgraded: Wall Street's top analyst calls (The Fly)
Jul-31-26 04:51PM	Illumina CEO on Genomic Sequencing Opportunities and AI (Bloomberg)
10:51AM	A spot is opening up in the S&P 500, and these stocks are top candidates to fill the void (MarketWatch)
08:30AM	Loading…
08:30AM	Illumina, Inc. Q2 2026 Earnings Call Summary (Moby)
01:04AM	Illumina Inc (ILMN) (Q2 2026) Earnings Call Highlights: Strong Clinical Growth Drives Revenue ... (GuruFocus.com)
Jul-30-26 04:40PM	Illumina: Q2 Earnings Snapshot (Associated Press) +5.27%
04:05PM	Illumina Reports Financial Results for Second Quarter of Fiscal Year 2026 (PR Newswire)
01:49PM	Scale AI names Francis deSouza as new CEO (Quartz)
11:04AM	Scale AI taps former Google Cloud executive as CEO (Reuters)
Jul-24-26 05:19PM	What Are You Really Paying For Inside IJH? (Trefis)
08:23AM	Reading Between The Lines Of DHR's Latest Call (Trefis)
Jul-20-26 12:06PM	Cathie Wood Dumps $39 Million Worth of AMD Stock (GuruFocus.com)
Jul-16-26 12:00PM	Illumina expands Billion Cell Atlas program with new AI drug developers (PR Newswire)
Jul-13-26 04:50PM	Alamar Hits A High Note On Alzheimer's Buzz (Trefis)
12:52PM	Cathie Wood Loads Up on SpaceX, Meta, Eli Lilly and Circle Group (GuruFocus.com)
Jul-09-26 04:05PM	Illumina to Announce Second Quarter 2026 Financial Results on Thursday, July 30, 2026 (PR Newswire)
09:05AM	Illumina appoints Michael Sullivan Chief Commercial Officer and Julie Coletti Chief Legal Officer (PR Newswire)
Jul-01-26 05:41PM	SkylineDxs Merlin CP-GEP Granted FDA Breakthrough Device Designation (Exec Edge)
Jun-30-26 11:58AM	Roche takes on Illumina with new NGS system (MedTech Dive)
Jun-23-26 09:05AM	Daniel M. Skovronsky, MD, PhD, appointed to Illumina's Board of Directors (PR Newswire)
Jun-10-26 03:43PM	Illumina upgraded to overweight at JPMorgan on clinical demand outlook (Investing.com)
09:42AM	Nike downgraded, Oscar Health upgraded: Wall Street's top analyst calls (The Fly)
Jun-09-26 12:30PM	Samsung Electronics invests $175 million in Element Biosciences' Series E funding round (Reuters)
12:25PM	Samsung Elec invests $175 million to become top shareholder in US genetics firm (Reuters)
Jun-08-26 09:15AM	Illumina launches StrataMap Spatial Solution, a powerful end-to-end spatial whole transcriptome research solution (PR Newswire)
May-28-26 11:06PM	Dow Jones Futures: Stock Market Hits Highs On U.S.-Iran Deal; Dell Surges On Earnings (Investor's Business Daily) +5.68%
12:30PM	Illumina and SPT Labtech unveil fireflyGO, enabling faster, simpler targeted oncology research (PR Newswire)
09:15AM	Illumina introduces the first distributed whole-genome sequencing solution for highly sensitive MRD research (PR Newswire)
May-21-26 04:15PM	David P. King elected to Illumina's Board of Directors (PR Newswire)
May-19-26 04:30PM	Illumina releases 2025 Corporate Responsibility Report, expanding access to genomics and accelerating global impact (PR Newswire)
May-15-26 09:45AM	Cisco upgraded, Doximity downgraded: Wall Street's top analyst calls (The Fly)
12:01AM	Nateras Stronghold in Cancer Recurrence Tests Prompts Woods Ark to Expand Stake (The Daily Upside)
May-11-26 03:34PM	Musk, Cook Expected to Join Trump for Xi Summit in China (Bloomberg)
May-06-26 09:31AM	Why The Dip In TEM Stock Is A Buying Window (Trefis)
May-01-26 08:30AM	Illumina, Inc. Q1 2026 Earnings Call Summary (Moby) +7.13%
03:17AM	Illumina Inc (ILMN) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Raised Guidance ... (GuruFocus.com)
Apr-30-26 04:36PM	Illumina: Q1 Earnings Snapshot (Associated Press) +5.29%
04:05PM	Illumina Reports Financial Results for First Quarter of Fiscal Year 2026 (PR Newswire)
Apr-16-26 09:15AM	DRAGEN v4.5 supports Illumina's new TruPath Genome and 5-base assays, drives insights across germline, oncology, and multiomic workflows (PR Newswire)
Apr-14-26 09:15AM	Illumina and the Center for Data-Driven Discovery in Biomedicine bring genomic data and scalable software to the fight against pediatric cancer and rare disease (PR Newswire)
Apr-09-26 04:30PM	Illumina to Announce First Quarter 2026 Financial Results on Thursday, April 30, 2026 (PR Newswire)
Apr-02-26 09:07AM	Illumina Announces Changes to Board of Directors (PR Newswire)
Mar-18-26 09:15AM	Illumina and Labcorp expand collaboration to broaden access to precision oncology testing (PR Newswire)
Mar-16-26 09:15AM	Illumina advances preventive genomics through strategic consortium with Veritas Genetics (PR Newswire)
Mar-09-26 09:50AM	Here's Why Illumina (ILMN) is a Strong Momentum Stock (Zacks)
Mar-06-26 09:40AM	Here's Why Illumina (ILMN) is a Strong Value Stock (Zacks)
Mar-05-26 09:15AM	Alliance for Genomic Discovery expands with Regeneron Genetics Center membership and new proteomics data offering (PR Newswire)
08:44AM	TEM's Diagnostics Arm Expanding Rapidly: What's Driving the Growth? (Zacks)
Mar-04-26 09:45AM	Why Illumina (ILMN) is a Top Growth Stock for the Long-Term (Zacks)
Mar-03-26 10:15AM	PacBio and DNAstack Collaborate on Global HiFi Genome Network Hub (Zacks)
Mar-02-26 05:32PM	Quanterix Q4 Earnings Call Highlights (MarketBeat)
Feb-27-26 09:15AM	Illumina whole-genome sequencing technology to accelerate rare disease testing in Florida (PR Newswire) +5.54%
Feb-26-26 10:48AM	TEM vs. ILMN: Which MedTech Stock Offers Greater Upside? (Zacks)
Feb-25-26 09:15AM	Illumina partners go beyond the genome, driving cancer breakthroughs using spatial transcriptomics, epigenomics, and proteomics (PR Newswire)
Feb-24-26 12:15PM	Illumina launches TruPath Genome, setting a new standard in genomic insight (PR Newswire)
Feb-23-26 09:15AM	Illumina unveils roadmap of groundbreaking NovaSeq X advancements in data quality, output, speed, and flexibility (PR Newswire)
Feb-20-26 04:26PM	This once-hot cancer-detection company's stock got cut in half after a failed trial (MarketWatch)
10:48AM	Genomics Stocks That Deserve a Place in Your Portfolio in 2026 (Zacks)
12:00AM	GRAIL Inc (GRAL) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Strategic Challenges (GuruFocus.com)
Feb-18-26 09:40AM	Why Illumina (ILMN) is a Top Value Stock for the Long-Term (Zacks)
06:02AM	The Quality Screened Mid Cap XMHQ ETF Rocketed 283% And Made Money The Easy Way (24/7 Wall St.)
Feb-17-26 03:10PM	Illumina To Webcast Upcoming Investor Conference (PR Newswire)
Feb-12-26 10:00AM	Devyser Diagnostics AB (FRA:OL0) Q4 2025 Earnings Call Highlights: Record Sales and Strategic ... (GuruFocus.com)
09:45AM	Illumina (ILMN) is a Top-Ranked Growth Stock: Should You Buy? (Zacks)
08:24AM	Illumina Q4 Earnings & Revenues Top Estimates, Stock Dips (Zacks)
12:36AM	5 Insightful Analyst Questions From Illumina's Q4 Earnings Call (StockStory)
Feb-09-26 11:19AM	Waters Q4 Earnings Call Highlights (MarketBeat)
09:15AM	Unlocking Illumina (ILMN) International Revenues: Trends, Surprises, and Prospects (Zacks)
Feb-06-26 01:25PM	Tech Bounces As Software Sell-Off Eases, Dow Jones Hits Records: What's Moving Markets Friday? (Benzinga) -10.40%
03:48AM	Analyst Report: Illumina, Inc. (Morningstar Research)
12:36AM	ILMN Q4 Deep Dive: Clinical Consumables Growth, Multiomics Expansion, and Margin Momentum (StockStory)
12:05AM	Illumina Inc (ILMN) Q4 2025 Earnings Call Highlights: Strong Clinical Growth Amidst Research ... (GuruFocus.com)
Feb-05-26 08:58PM	Illumina Q4 Earnings Call Highlights (MarketBeat)

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Meister Keith A.	Director	Sep 04 '26	Sale	218.40	119,501	26,098,466	770,350	Sep 04 06:43 PM
Meister Keith A.	Director	Sep 03 '26	Sale	218.23	75,951	16,574,481	889,851	Sep 04 06:43 PM
Meister Keith A.	Director	Sep 02 '26	Sale	213.28	68,108	14,526,254	965,802	Sep 04 06:43 PM
Corvex Management LP	Affiliate of Director (1)	Sep 04 '26	Proposed Sale	213.25	150,000	31,987,500		Sep 04 04:05 PM
Meister Keith A.	Director	Aug 27 '26	Sale	228.89	138,379	31,673,778	1,033,910	Aug 27 07:35 PM
Meister Keith A.	Director	Aug 25 '26	Sale	225.51	131,019	29,546,639	1,278,832	Aug 27 07:35 PM
Meister Keith A.	Director	Aug 26 '26	Sale	225.46	106,543	24,021,247	1,172,289	Aug 27 07:35 PM
Corvex Management LP	Affiliate of Director (1)	Aug 27 '26	Proposed Sale	224.84	200,000	44,968,000		Aug 27 04:31 PM
Corvex Management LP	Affiliate of Director (1)	Aug 25 '26	Proposed Sale	223.22	300,000	66,966,000		Aug 25 04:17 PM
Meister Keith A.	Director	Aug 21 '26	Sale	217.96	299,336	65,243,445	1,409,851	Aug 21 07:42 PM
Meister Keith A.	Director	Aug 20 '26	Sale	213.86	285,238	61,000,127	1,709,187	Aug 21 07:42 PM
Meister Keith A.	Director	Aug 19 '26	Sale	203.29	95,000	19,312,827	1,994,425	Aug 21 07:42 PM
Corvex Management LP	Affiliate of Director (1)	Aug 21 '26	Proposed Sale	213.24	250,000	53,310,000		Aug 21 04:04 PM
Wedel Christensen Jakob	SVP, Strategy/Corp Development	Aug 18 '26	Sale	191.52	1,033	197,840	14,023	Aug 20 04:09 PM
Corvex Management LP	Affiliate of Director (1)	Aug 20 '26	Proposed Sale	205.00	355,000	72,775,000		Aug 20 04:05 PM
JAKOB WEDEL	Officer	Aug 18 '26	Proposed Sale	193.14	1,033	199,508		Aug 18 04:30 PM
Meister Keith A.	Director	Aug 04 '26	Sale	200.10	457,858	91,616,565	2,372,694	Aug 06 04:54 PM
Meister Keith A.	Director	Aug 05 '26	Sale	199.61	283,269	56,543,331	2,089,425	Aug 06 04:54 PM
Corvex Management LP	Affiliate of Director (1)	Aug 04 '26	Proposed Sale	198.16	840,000	166,454,400		Aug 04 05:02 PM
Davies Scott M	Chief Legal Officer	Jul 30 '26	Sale	200.00	615	123,000	20,338	Aug 03 04:24 PM
SCOTT DAVIES	Officer	Jul 30 '26	Proposed Sale	194.82	615	119,814		Jul 30 04:22 PM
Davies Scott M	Chief Legal Officer	Jun 25 '26	Sale	180.00	615	110,700	20,953	Jun 25 09:41 PM
SCOTT DAVIES	Officer	Jun 25 '26	Proposed Sale	175.09	615	107,680		Jun 25 04:26 PM
FRANCES ARNOLD	Former Director	Jun 25 '26	Proposed Sale	181.49	2,000	362,980		Jun 25 04:04 PM
Leckman Patricia	SVP, Chief People Officer	Jun 05 '26	Sale	162.59	783	127,305	21,259	Jun 09 04:32 PM
Leckman Patricia	Officer	Jun 05 '26	Proposed Sale	167.58	783	131,215		Jun 05 04:03 PM
Leckman Patricia	SVP, Chief People Officer	Jun 02 '26	Sale	162.08	784	127,068	22,042	Jun 04 04:11 PM
FRANCES ARNOLD	Former Director	Jun 02 '26	Proposed Sale	161.52	3,000	484,572		Jun 02 04:37 PM
Leckman Patricia	Officer	Jun 02 '26	Proposed Sale	162.08	784	127,067		Jun 02 04:21 PM
Meister Keith A.	Director	Jun 01 '26	Sale	163.63	235,000	38,454,184	2,830,452	Jun 01 06:04 PM
Meister Keith A.	Director	May 29 '26	Sale	163.51	214,596	35,088,915	3,065,452	Jun 01 06:04 PM
Meister Keith A.	Director	May 28 '26	Sale	152.27	220,000	33,499,532	3,280,048	Jun 01 06:04 PM
Davies Scott M	Chief Legal Officer	May 29 '26	Sale	160.00	615	98,400	21,568	Jun 01 04:30 PM
Ericksen Scott D	VP, Chief Accounting Officer	May 28 '26	Sale	150.10	1,500	225,150	14,946	Jun 01 04:27 PM
Ericksen Scott D	VP, Chief Accounting Officer	May 29 '26	Sale	160.00	500	80,000	14,446	Jun 01 04:27 PM
Corvex Management LP	Affiliate of Director (1)	May 29 '26	Proposed Sale	158.70	400,000	63,480,000		May 29 06:14 PM
SCOTT ERICKSEN	Officer	May 29 '26	Proposed Sale	158.70	500	79,350		May 29 04:24 PM
SCOTT DAVIES	Officer	May 29 '26	Proposed Sale	158.70	615	97,600		May 29 04:24 PM
SCOTT ERICKSEN	Officer	May 28 '26	Proposed Sale	150.17	1,500	225,255		May 28 04:36 PM
FRANCES ARNOLD	Former Director	May 28 '26	Proposed Sale	156.13	5,000	780,650		May 28 04:08 PM
Meister Keith A.	Director	May 13 '26	Sale	145.55	225,067	32,759,594	3,604,441	May 14 07:21 PM
Meister Keith A.	Director	May 14 '26	Sale	145.34	104,393	15,172,381	3,500,048	May 14 07:21 PM
Corvex Management LP	Affiliate of Director (1)	May 13 '26	Proposed Sale	145.70	600,000	87,420,000		May 13 05:36 PM
Wedel Christensen Jakob	SVP, Strategy/Corp Development	May 06 '26	Sale	139.04	700	97,328	15,056	May 07 06:20 PM
JAKOB WEDEL	Officer	May 06 '26	Proposed Sale	139.04	700	97,328		May 06 04:10 PM
Davies Scott M	Chief Legal Officer	Feb 20 '26	Sale	116.18	1,336	155,216	16,334	Feb 24 04:11 PM
SCOTT DAVIES	Officer	Feb 20 '26	Proposed Sale	120.00	1,336	160,320		Feb 20 04:28 PM
Leckman Patricia	SVP, Chief People Officer	Feb 18 '26	Sale	116.18	2,370	275,347	16,321	Feb 18 04:49 PM
PATRICIA L LECKMAN	Officer	Feb 18 '26	Proposed Sale	116.18	2,370	275,347		Feb 18 04:22 PM
Barnard Steven	SVP, Chief Technology Officer	Feb 12 '26	Option Exercise	0.00	2,677	0	35,708	Feb 17 04:55 PM
Thaysen Jacob	Chief Executive Officer	Feb 12 '26	Option Exercise	0.00	13,264	0	95,353	Feb 17 04:53 PM
Pegels Kevin Carl	Chief of Global Operations	Feb 12 '26	Option Exercise	0.00	2,283	0	24,759	Feb 17 04:48 PM
Davies Scott M	Chief Legal Officer	Feb 12 '26	Option Exercise	0.00	1,370	0	19,257	Feb 17 04:46 PM
Leckman Patricia	SVP, Chief People Officer	Feb 12 '26	Option Exercise	0.00	1,028	0	20,419	Feb 17 04:45 PM
Ericksen Scott D	VP, Chief Accounting Officer	Feb 12 '26	Option Exercise	0.00	743	0	14,229	Feb 17 04:44 PM
Gottlieb Scott	Director	Feb 09 '26	Buy	117.81	200	23,562	12,723	Feb 11 04:04 PM
Davies Scott M	Chief Legal Officer	Dec 12 '25	Sale	136.09	323	43,957	17,887	Dec 16 05:00 PM
SCOTT DAVIES	Officer	Dec 12 '25	Proposed Sale	136.09	323	43,957		Dec 12 04:09 PM
Wedel Christensen Jakob	SVP, Strategy/Corp Development	Dec 08 '25	Sale	129.27	549	70,969	10,952	Dec 09 04:15 PM
JAKOB WEDEL	Officer	Dec 08 '25	Proposed Sale	129.27	549	70,969		Dec 08 04:31 PM
SCOTT DAVIES	Officer	Nov 12 '25	Proposed Sale	122.79	323	39,661		Nov 12 04:05 PM
Gottlieb Scott	Director	Nov 03 '25	Buy	122.13	500	61,065	12,523	Nov 05 04:05 PM

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.

CEOMr. Jacob Thaysen Ph.D.

Chief Financial OfficerMr. Ankur Dhingra CPA

Chief of Global OperationsMr. Kevin Carl Pegels

Chief Technology OfficerDr. Steven Barnard Ph.D.

VP & Chief Accounting OfficerMr. Scott Ericksen

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ILMN

Illumina Inc

Upgrade your Finviz experience